Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2015 000 054.1 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Secukinumab |
54 | Title of basic patent | TIGZ | ANTAGONISTISCHE ANTIKÖRPER GEGEN IL-17 |
51 | IPC main class | ICM (ICMV) | C07K 16/24 (2006.01) |
94 | Start of term of protection | LB | Aug 5, 2025 |
94 | End of term of protection | LE | Jul 19, 2030 |
22 | DE application date | DAT | Jul 6, 2015 |
| Date of publication of application for a certificate | OT | Aug 27, 2015 |
| Date of publication of grant of certificate | PET | Feb 2, 2023 |
71/73 | Applicant/owner | INH | Novartis AG, Lichtstraße 35, 4056 Basel, CH |
74 | Representative | VTR | Breuer, Markus, Dr., 80331 München, DE |
| Address for service | | Breuer, Markus, Dr., 80333 München, DE |
| Due date | FT FG | Aug 31, 2026 Annual fee for the 22nd year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 60 2005 029 231.4 |
68 | EP file number of basic patent | GEAKZ | 05 77 0286.2 |
43 | Date of first publication | EVT | Aug 27, 2015 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/14/980/001-007 2015-01-15
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/14/980/001-007 2015-01-15
|
| Date of the first transfer into DPMAregister | EREGT | Aug 27, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 8, 2025 (Show all update days)(Hide all update days)- Aug 8, 2025
- Aug 14, 2024
- St.36: changed (technical change)
- Mar 13, 2024; Mar 9, 2023; Feb 9, 2023; Jan 26, 2023; Jan 4, 2023; Dec 28, 2022; Dec 17, 2022; Nov 15, 2022; Nov 11, 2022; Oct 25, 2022; Oct 19, 2022; Sep 8, 2022; Aug 2, 2022; Feb 5, 2022; Sep 6, 2019; Jul 16, 2019; Oct 21, 2017
- Historical data not available for this/these date(s)
- Aug 27, 2015
- Date of the first transfer into DPMAregister
|
View procedures New representative details (No.: 2)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New representative details |
| Legal/procedural status | VST | New representative details |
| Date of legal/procedural status | VSTT | Sep 5, 2019 |
74 | Representative | VTR | Breuer, Markus, Dr., 80331 München, DE |
74 | Previous representative | VTRF | Henkel, Breuer & Partner, 80333 München, DE |
| Date of update of the procedure | REGT | Mar 13, 2024 |